This map shows the geographic impact of Epstein Se's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Epstein Se with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Epstein Se more than expected).
This network shows the impact of papers produced by Epstein Se. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Epstein Se. The network helps show where Epstein Se may publish in the future.
Co-authorship network of co-authors of Epstein Se
This figure shows the co-authorship network connecting the top 25 collaborators of Epstein Se.
A scholar is included among the top collaborators of Epstein Se based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Epstein Se. Epstein Se is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
16 of 16 papers shown
1.
Se, Epstein, et al.. (1996). Apoptosis in vascular disease: opportunities for genetic therapeutic intervention.. PubMed. 1(3). 195–202.5 indexed citations
2.
Ro, Bonow, et al.. (1988). Medical and surgical therapy of hypertrophic cardiomyopathy.. PubMed. 19(1). 221–39.12 indexed citations
3.
Ro, Bonow, et al.. (1984). Verapamil therapy for the management of hypertrophic cardiomyopathy. 313–339.1 indexed citations
4.
Goldstein, Susan, et al.. (1983). CONTRASTING EFFECTS OF VERAPAMIL AND NIFEDIPINE ON PH OF ISCHEMIC MYOCARDIUM DURING FIXED CORONARY-OCCLUSION. Journal of the American College of Cardiology. 1(2). 677.3 indexed citations
5.
Ro, Bonow, Epstein Se, & Robert O. Bonow. (1981). Effects of verapamil on left ventricular filling in patients with hypertrophic cardiomyopathy. 363–369.1 indexed citations
6.
Ra, Goldstein, et al.. (1980). Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia.. PubMed. 11(4). 295–313.6 indexed citations
7.
Bj, Maron, et al.. (1980). Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.. PubMed. 3(1-2). 195–203.63 indexed citations
8.
Bj, Maron & Epstein Se. (1979). Clinical course of patients with hypertrophic cardiomyopathy.. PubMed. 10(1). 253–65.1 indexed citations
9.
Bj, Maron, et al.. (1978). Long-term hemodynamic and electrocardiographic assessment following operative repair of tetralogy of Fallot.. PubMed. 58(3 Pt 2). I209–17.50 indexed citations
10.
Se, Epstein, et al.. (1977). Clinical and hemodynamic results following triple valve replacement: mechanical vs porcine xenograft prostheses.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 56(3 Suppl). II122–7.6 indexed citations
11.
Se, Epstein, et al.. (1977). Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.. PubMed. 52(22). 875–9.6 indexed citations
12.
Bj, Maron, et al.. (1977). Pathophysiology of asymmetric septal hypertrophy.. PubMed. 20(3-4). 359–66.
13.
Se, Epstein, et al.. (1976). Protection of ischemic myocardium by nitroglycerin: experimental and clinical results.. PubMed. 53(3 Suppl). I191–8.23 indexed citations
14.
Se, Epstein, et al.. (1975). Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience.. PubMed. 78(6). 768–75.91 indexed citations
15.
Wc, Roberts, et al.. (1972). Current status of the Starr-Edwards cloth-covered prosthetic cardiac valves.. PubMed. 45(1 Suppl). I14–24.44 indexed citations
16.
Se, Epstein, et al.. (1971). Potentiation of the inotropic effects of glucagon by theophylline.. PubMed. 179(2). 331–7.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.